Manual Therapy Interventions For Patients With Lumbar Spinal Stenosis: A Systematic Review
Manual Therapy Interventions For Patients With Lumbar Spinal Stenosis: A Systematic Review
ABSTRACT
Objective: The objective of this paper is twofold (1) determine the quality of current
available studies regarding the use of manual therapy intervention for the treatment
of lumbar spinal stenosis LSS and (2) determine the effectiveness of manual therapy
for the treatment of LSS.
Data sources: A literature search was conducted using the MEDLINE, CINAHL, PEDro
and Cochrane Controlled Trials databases. Clinical trials and observational studies
were also included.
Review methods: Abstracts of potentially relevant articles were reviewed and
screened for inclusion criteria. The quality of the relevant articles after abstract
screening was measured against the nineteen item Maastricht-Amsterdam criteria
list. Two reviewers independently assessed the relevant articles using these criteria.
Overall methodological quality scores and internal validity scores were determined
by adding the positive scores from their respective criteria.
Results: Thirty-one relevant studies were identified. Twenty of these studies were
excluded, leaving eleven studies meeting inclusion criteria for review. Overall
methodological quality of the eleven studies was poor. Only one high quality
randomized controlled trial (RCT) was identified.
Conclusion: Based on this systematic review, preliminary evidence indicates that
manual therapy combined with exercise demonstrates potential benefit in the
treatment of LSS, but further evidence of effectiveness is needed. Reiman MP, Harris
JY, Cleland JA (2009): Manual therapy interventions for patients with lumbar spinal
stenosis: a systematic review. New Zealand Journal of Physiotherapy 37(1) 17-28.
Key Words: spinal stenosis, lumbar spine, systematic review
a maximum score of nineteen. Items that refer to Table 2: The criteria list from the Cochrane Back Review
Group*
internal validity include criteria B, E, F, G, H, I, J,
L, N, P (van Tulder et al., 1997). External validity A Were the eligibility criteria specified?
is evaluated with the descriptive criteria (A, C, D, B. 1Was a method of randomization performed?
K, M), while the remaining two items (O, Q) are B. 2Was the treatment allocation concealed?
C. Were the groups similar at baseline?
statistical criteria. D. Were the experimental and control interventions
An internal validity score (IVS) was also given explicitly described?
by adding the positive scores for internal validity E. Was the care provider blinded to the intervention?
F. Were the co-interventions avoided or comparable?
items (van Tulder et al., 1997; Peeters et al., 2001; G. Was the compliance acceptable in all groups?
Verhagen et al., 2002). A score of greater than 50% H. Was the patient blinded to the intervention?
for the study on overall QS or IVS was considered I. Was the outcome assessor blinded to the
intervention?
of acceptable validity (Verhagen et al. 2002). J. Were outcome measures relevant?
K. Were adverse effects described?
DATA ABSTRACTION L. Was the withdrawal/drop-out rate described and
acceptable?
Two reviewers (MR and JH) independently read, M. 1 Was a short-term follow-up measurement performed?
examined, and extracted the necessary key data M. 2 Was a long-term follow-up measurement performed?
in the appropriate categories: characteristics of N. Was the timing of the outcome assessment in both
groups comparable?
patients (age, gender and diagnosis), treatments O. Was the sample size for each group described?
utilized, outcome measures assessed, and the P. Did the analysis include an intention-to-treat analysis?
! Q. Were point estimates and measures of variability
results of the respective studies. Any disagreements
presented for the primary outcome measures?
related to differences in interpretation of the criteria
were resolved with both authors reviewing the *van Tulder et al., 1997
article a second time and additional discussion.
A B1 B2 C D E F G H I J K L M1 M2 N O P Q OQS IVS
Whitman et al Y Y Y Y Y N Y Y N Y Y N Y Y Y Y Y Y Y 16 9
(2006)
Atlas et al Y N N N N N DK Y N DK Y N Y Y Y Y Y N Y 9 4
(1996)
Atlas et al Y N N N N N DK Y N DK Y N Y Y Y Y Y N Y 9 4
(2000)
Atlas et al Y N N N N N DK Y N DK Y N Y Y Y Y Y N Y 9 4
(2005)
Athiviraham et Y N N N N N DK Y N N Y Y Y N Y Y Y N N 6 3
al (2007)
Creighton et al Y N N DK N N DK Y N N Y N N Y Y N N N N 5 2
(2006)
Murphy et al Y N N N N N DK DK N DK Y Y DK Y Y N N N Y 5 1
(2006)
Simotas et al Y N N N N N DK DK N DK Y N DK DK Y N Y N Y 5 1
(2000)
Whitman et al Y N N N N N Y DK N N Y N N Y Y N N N N 5 2
(2003)
Snow et al N N N N N N Y DK N N Y N N Y Y N N N N 4 2
(2001)
Dupriest et al N N N N N N DK DK N N Y N N Y Y N N N N 3 1
(1993)
A few limitations exist in this systematic review. fact that only the first author selected the articles
Firstly, studies published in languages other than could also result in selection bias. A blinding
English were excluded for this review. This could mechanism of the articles was not implemented as
result in language bias and decrease precision. The the first author (MR) was also primarily involved
Table 5: Level of evidence levels for treatment comparisons identified in the review.
*According to the criteria for the levels of evidence described by van Tulder et al (2003), Level 2 evidence requires one high quality
RCT and one or more lower quality RCTs. We awarded a Level 2 rating for the evidence, on the basis of one high quality RCT and
accepting generally consistent findings in several non-randomized studies in lieu of one or more lower quality RCTs. The criteria for the
levels of evidence described by van Tulder et al (2003) do not cover the situation of one high quality RCT alone.